ᅟ. ; ᅟ [http://​darwin.​phyloviz.​net/​ComparingPartiti​ons/​index.​php?​link=​Home] 30. Carriço JA, Silva-Costa C, Melo-Cristino J, Pinto FR, De Lencastre H, Almeida JS, Ramirez M: Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol

2006, 44:2524–2532.PubMedCentralPubMedCrossRef 31. Hall T: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41:95–98. 32. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731–2739.PubMedCentralPubMedCrossRef 33. Sheppard SK, McCarthy ND, Falush D, Maiden MCJ: Convergence

of Campylobacter species: implications for bacterial evolution. Science Roxadustat research buy 2008, 320:237–239.PubMedCrossRef 34. Korczak BM, Zurfluh M, Emler S, Kuhn-Oertli J, Kuhnert P: Multiplex strategy for multilocus sequence typing, fla typing, and genetic determination of antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolates collected in Switzerland. J Clin Microbiol 2009, 47:1996–2007.PubMedCentralPubMedCrossRef 35. Said MM, El-Mohamady H, El-Beih FM, Rockabrand DM, Ismail TF, Monteville MR, Ahmed SF, Klena JD, Salama MS: Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR. J Infect Dev Ctries 2010, 4:546–554.PubMedCrossRef 36. Sheppard SK, Didelot X, Jolley KA, Darling AE, Pascoe B, Meric G, Kelly DJ, Cody A, Colles FM, Strachan NJC, AZD6244 in vitro Ogden ID, Forbes K, French NP, Carter P, Miller WG, McCarthy ND, Owen R, Litrup E, Egholm M, Affourtit JP, Bentley SD, Parkhill J, Maiden MCJ, Falush D: Progressive genome-wide introgression in agricultural Campylobacter coli. Mol Ecol 2013, 22:1051–1064.PubMedCentralPubMedCrossRef 37. Ribosomal Multilocus Ergoloid Sequence Typing (rMLST) – PubMLST.org.; ᅟ [http://​pubmlst.​org/​rmlst/​] 38. Sheppard SK, Dallas JF, Wilson DJ, Strachan NJC, McCarthy ND, Jolley KA, Colles FM, Rotariu O, Ogden ID, Forbes

KJ, Maiden MCJ: Evolution of an agriculture-associated disease causing Campylobacter coli clade: evidence from national surveillance data in Scotland. PLoS One 2010, 5:e15708.PubMedCentralPubMedCrossRef 39. Raghavan R, Kelkar YD, Ochman H: A selective force favoring increased G + C content in bacterial genes. Proc Natl Acad Sci U S A 2012, 109:14504–14507.PubMedCentralPubMedCrossRef 40. Foerstner KU, Von Mering C, Hooper SD, Bork P: Environments shape the nucleotide composition of genomes. EMBO Rep 2005, 6:1208–1213.PubMedCentralPubMedCrossRef 41. Colles FM, Ali JS, Sheppard SK, McCarthy ND, Maiden MCJ: Campylobacter populations in wild and domesticated Mallard ducks (Anas platyrhynchos). Environ Microbiol Rep 2011, 3:574–580.PubMedCentralPubMedCrossRef 42.

Relative expression of tlp genes by qPCR In order to determine relative gene expression profiles of the C. jejuni group A tlp genes at varying conditions in vitro and in vivo, C. jejuni strains, 11168-GS, 11168-O and 81116 were grown in vitro, at 37°C, 42°C and maintained in pond water at 20–25°C, and in vivo by colonising avian and mammalian hosts and then isolated directly from animals

by immunomagnetic separation (IMS) (Methods). Growth at 37°C, 42°C was assessed as it mimics mammalian and avian hosts in vitro and allows S1P Receptor inhibitor a direct comparison with expression of Tlps in cells directly isolated from animal hosts. Maintenance in pond water (from local farm pond, sterilised) at 20–25°C is used to mimic environmental conditions [12], as surface and reservoir water contamination is a potential environmental source for C. jejuni outbreaks [13–16]. Relative gene expression of the group A tlp receptors in C. jejuni under all these different conditions was then assessed by Quantitative PCR. The expression of tlp genes was compared between each strain and growth condition. Only statistically significant differences (p < 0.05) are described below. Comparison of the group A tlp gene expression for C. jejuni 11168-O, 11168-GS and 81116 The expression levels of tlp genes within C. jejuni strain 11168-O were Selleckchem CH5424802 generally varied, with tlp7 and 10 showing higher expression

PJ34 HCl levels compared to the other tlp genes. It is interesting to note that tlp1 showed the lowest level of expression (Figure 1), particularly in cells isolated from the intestines of chicks and from bacteria grown in laboratory conditions at 42°C. Contrary to all expectations, the expression of tlp7 was very high under all conditions tested, irrespective of the fact that it is a present as two separate gene transcripts in C. jejuni 11168-O (Figure 1). This high

level of expression correlated with the finding that tlp7 may act as a functional receptor even when present as two separate genes [8]. Figure 1 Expression of Group A tlp genes for C. jejuni strain 11168-O. Relative gene expression profiles of Group A tlp genes for C. jejuni 11168-O grown at 37°C, 42°C, maintained in pond water and isolated in vivo from chicken and mouse. Expression is standardised and the scale is shown in log (copies per 108 of 23 S RNA). 37: grown under laboratory conditions at 37°C, 42: grown under laboratory conditions at 42°C, pond: maintained in an environmental water source at room temperature, 22°C, chicken: directly isolated from chicken caecal content by Dyna-beads, mouse: directly isolated from mouse intestines by Dyna-beads. Standard errors are shown as bars above the mean of a minimum of 3 independent PCR reactions. In contrast, the expression profiles for the group A tlp genes in C. jejuni 11168-GS all displayed similar patterns of gene expression.

cholerae strains. This procedure could help to determine how relevant the expression of kdpD in V. cholerae is and whether the expression of other genes is reduced or induced in the resistant strains. Conclusions In a high-troughput screening assay with 28,300 compounds the synthetic small molecule vz0825 was identified as the most active antibacterial substance against V. cholerae with an MIC of

1.6 μM and an MBC of 3.2 μM. Whole genome sequencing was carried out with resistant mutants and the two-component histidine kinase KdpD was identified as the prime target of the substance. Further investigations should address the inhibitory mechanism in more detail and corroborate on the possibility of an essential function of KdpD in V. cholerae. Histidine kinase inhibitors are in principal promising antimicrobial drug candidates [30] and compounds like vz0825

JNK inhibitor may lead to new treatment options. Methods Strains, media and plasmids The strains used in this study are listed in Table  3. Reporter strain MO10 pG13 was generated from the pathogenic wild type strain MO10, serogroup O139, which was electroporated with the plasmid construct pG13 containing a kanamycin resistance gene (Kmr) and was selected on a plate containing 30 μg/ml Km. V. cholerae strains were grown in LB medium (pH 7.0) at 37°C. LB medium containing Km (30 μg/ml) was used for HTS and Cip (100 μM) was used for positive control. To determine the MIC and MBC values, Mueller-Hinton of (MH) broth (pH 7.4) was used as growth medium. Susceptibility to ampicillin (Amp), tetracycline selleck compound (Tet), Cip, rifampicin, chloramphenicol, erythromycin, sulfamethoxazole, and trimethoprim/sulfamethoxazole (SXT) was determined in 96-well MTP containing MH medium supplemented with varied amounts (1 to 1,024 μg/ml) of each antibiotic separately and varied amounts of SXT (0.13/2.38 to 8/152 μg/ml). Supplemented LB medium with Amp (50 μg/ml), Km (30 μg/ml) and Carb (100 μg/ml) was used during the procedures of site-directed mutagenesis and in T medium pH 7.4.

T medium was prepared by adding 17 g tryptone, 3 g neutralized soy peptone, 10 g glucose, 50 mM MOPS, 100 mM NaCl, 2 mM KCl and 2 mM CaCl2 in 1 l of water. For homolog recombination NaCl-free (for increased sucrose sensitivity [31]) LB medium or T medium with 10% sucrose (for induction of pEX18Ap plasmid excision, carrying the sacB gene) was used. Cultivation of the mouse fibroblas cell line L292 was carried out in DMEM with 10% FBS (Lonza). Substance collections Three commercially available substance collections were used in the screening campaigns: i) the LOPAC collection of pharmacologically active compounds with 1,408 entities (Sigma-Aldrich); ii) the Echaz Microcollection with 7,304 compounds (EMC Microcollections GmbH, Tübingen, Germany); and iii) the CDI collection with approximately 17,000 compounds (Chemical Diversity Lab, Inc.

Secondary incubation of the membrane was then carried out using a 1:5000 dilution of goat antimouse or anti-rabbit IgG tagged with horseradish peroxidase. The blot was developed using Opti-4CN substrate kit (Bio-Rad Laboratories, Hercules, CA). The blots were scanned using the Biophotonics system (Biophotonics Corp., Ann Arbor, MI). The band intensity was evaluated using the Intelligent

Quantifier software (Bio Image, Ann Arbor, MI). The overexpression of eIF4E and TLK1B was quantified as x-fold over the samples of benign tissue from noncancer specimens run concurrently on the gel. Analysis of TMAs The first TMA (TMA1) was constructed to optimize antibody dilutions. The second TMA (TMA2) was designed with triplicate specimens to analyze intra-individual variability. In this Epigenetic Reader Domain inhibitor regard, three separate plugs from each patient were taken from each original block and re-imbedded into TMA2. Replicate breast tumor specimens were MK-8669 mw analyzed for plug-to-plug reproducibility by staining the TMAs immunohistochemically and quantitating them using the ARIOL imaging system (described below). The third TMA (TMA3) was designed to compare eIF4E to its downstream effector

proteins using a larger set of breast cancer specimens. ARIOL Imaging The ARIOL imaging system (Genetix, San Jose, CA) was used to quantify antibody staining of the TMAs. The specimens were scanned at a low resolution (1.25×) and high resolution (20×) using Olympus BX 61 microscope

with an automated platform (Prior). The slides were loaded in the automated slide loader (Applied Imaging SL 50). The images with high resolution were used for training and quantification purpose. The system was trained to select the stained and unstained cells/nuclei by the color of staining and shape of nuclei such that brown staining was considered positive and blue staining was considered negative. The number of cells/nuclei stained was calculated and represented as Janus kinase (JAK) percentage of total cells/nuclei stained positively. By measuring both immunostaining intensity and percentage, data obtained are reproducible, objective measurements of immunoreactivity. Because standardizing IHC, from the fixation of tissues to the analysis of IHC results is critical, all immunohistochemistry data were normalized to cytokeratin. To control for the variability in tumor cellularity from one patient to another, and to also control for variations in the number of tumor cells at different TMA spots (intra-tumoral variations), the number of epithelial (tumor) cells present at each TMA spot as highlighted by expression of cytokeratin 7, was used for normalization of each protein expression studied [26]. For each protein, a score was generated based on the area with and the intensity of the brown staining reaction. The scores were then exported to an Excel spreadsheet for analysis.

Using this information, we also calculated the 10-year probability of major osteoporotic fractures using the version 3 of FRAX® web-based tool [20]. VFA images and BMD measurements of the lumbar spine and proximal femur were obtained by two ISCD-certified technologists using a Prodigy densitometer (GE Medical Systems, Madison, WI, USA). All VFA images were evaluated by one ISCD-trained clinician (TJV) using Genant semi-quantitative approach [21] as recommended by the ISCD [14, 22] where vertebra with a fracture

on visual inspections is assigned the following grades: grade 1 (mild) fracture represents a reduction in vertebral height of 20–25%; grade 2 (moderate) a reduction of 26–40%; and grade 3 (severe) a reduction SCH772984 nmr of over 40%. A subject in the vertebral fracture group had at least one grade 2 fracture or two grade 1 fractures. The main analysis was performed after excluding subjects with a single grade 1 fracture (N = 31) because it is often not clear whether these represent true fractures or non-fracture deformities, because grade 1 fractures are not as

clearly predictive of future fractures as are higher grades [23], RXDX-106 in vivo and because they are often difficult to conclusively diagnose on VFA [14, 22, 24]. Definition of risk factors used in analysis Height loss was calculated by subtracting the measured height from the self-reported young Thiamet G adult height. Self-reported vertebral fractures were present if the subject reported spine or vertebral fractures (excluding neck or cervical fractures) in response to the question “have you had any broken bones”. Non-vertebral (peripheral) fracture was

defined as any fracture occurring after age 25, in the course of usual physical activity, excluding fractures of the face, fingers, and toes, or those resulting from a motor vehicle accident. Glucocorticoid use (systemic but not inhaled) was defined as at least 5 mg/day of prednisone or equivalent for at least 3 months (cumulative exposure equivalent to at least 0.450 g of prednisone), as recommended by the American College of Rheumatology [25]. For BMD measurement, the lower of the lumbar spine or proximal femur T-score (femoral neck or total hip) was used for analysis as recommended by the ISCD [26]. Statistical analysis All analyses were performed using STATA statistical software package [27]. The differences in the clinical characteristics and risk factors between men and women and between subjects with and without vertebral fractures were compared using t tests for continuous variables and chi-square tests for categorical variables. The association between vertebral fracture and risk factors was modeled using logistic regression. Given the known gender differences in prevalence of and risk factors for vertebral fractures, all analyses were a priori stratified by gender.

Although our results are limited by relatively small number of patients, due to the relatively low incidence of MPM, our data strongly support that Hh signaling plays indispensable roles in mesothelioma, and exerts significant impact on the prognosis of mesothelioma patients. Figure 6 Real-time RT-PCR analysis of expression level of (A) SMO and

(B) SHH in MPM tissue samples. X-axis represents Relative expression level of SMO (A) or SHH (B) mRNA (arbitrary units). Y-axis represents percentage of the MPM tissue samples analyzed. As deregulated Hh signaling pathway has been implicated in many different types of cancer, and inhibition of Hh signaling leads to suppression of tumor growth [10, 11], we addressed whether Hh signaling plays critical roles in proliferation of mesothelioma cells. Remarkably, we observed elevated endogenous SMO expression in 3 mesothelioma selleck screening library cell lines tested (Figure 5A). Furthermore, utilizing a specific Hh inhibitor cycloplamine, which significantly suppressed expression of Gli downstream targets (Figure 4), we observed significant inhibition of cell proliferation in all 3 mesothelioma cell lines examined (Figure 5B-D). These data indicate that aberrant Hh activation plays critical roles in tumor cell proliferation in mesothelioma, Selleckchem Navitoclax consistent with recent data by Shi Y et al. [8]. Conclusions Taken together, our results demonstrated a strong association between higher SMO and SHH

expression levels with poorer overall survival. Furthermore, we showed inhibition of Hh signaling blocked cell proliferation in multiple mesothelioma cell lines, strongly supporting that aberrant Hh signaling is essential Bay 11-7085 for tumor growth in mesothelioma. Therefore our findings revealed the hitherto unappreciated roles of Hh activation in MPM, and pinpointed Hh signaling antagonist as a potential new therapy against this devastating disease. Acknowledgements This work was supported by NIH/NCI grants R01CA125030 and R01CA132566, the Eileen D. Ludwig Endowed for Thoracic Oncology Research, the Kazan, McClain, Abrams,

Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Paul and Michelle Zygielbaum, and the Jeffrey and Karen Peterson Family Foundation, and by a Zhejiang Provincial Natural Science Foundation grant to F. Zhang (Y2110030). References 1. Bianchi C, Bianchi T: Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007,45(3):379–387.PubMedCrossRef 2. Robinson BW, Musk AW, Lake RA: Malignant mesothelioma. Lancet 2005,366(9483):397–408. ReviewPubMedCrossRef 3. Mott FE: Mesothelioma: a review. Ochsner J. 2012,12(1):70–79.PubMed 4. Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995,108(4):1122–1128.PubMedCrossRef 5. Heintz NH, Janssen-Heininger YM, Mossman BT: Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.

6 Hypothetical result when evaluating the effectiveness of road mitigation measures at a new road with mitigation. The new road with mitigation is constructed at time zero. In addition to the mitigation site, measurements are carried out—before and after road construction—at a no-mitigation control site and a no-road control site. Generally, there are four possible scenarios 1 the road mitigation measures are 100 % effective and population density remains at the level of the no-road control site, 2 the road mitigation measures are only partly effective selleck kinase inhibitor and population density decreases compared to the no-road control site but does not reach the level of the no-mitigation

Afatinib in vivo control site, 3 the road mitigation measures are not effective and population

density decreases to the level of the no-mitigation control site, 4 the road mitigation measures worsen the situation and population density decreases below the level of the no-mitigation control site All control sites need to be far enough away from the mitigation sites and each other to ensure statistical independence, yet still be as similar as possible. If possible, control sites should be sited along the same road as the mitigation site(s), as road age, design and traffic characteristics of the same section of road are probably similar. Such control sites should never immediately border the mitigation site(s), as possible edge effects of mitigation measures, e.g., an unnaturally high number of road-kill just at the end of the wildlife fencing, may influence the measurements. Select appropriate Adenosine spatial scale of study Two factors need to be considered when determining the spatial scale of a study. First, the spatial scale of the study should match the spatial scale of the effect being mitigated. Stipulating a one-size fits all approach to determine the spatial scale of the study is not possible because the size of the road effect zone (Forman and Deblinger 2000; Forman et al. 2003) varies depending on the

effect, the species of concern, and the local situation (e.g., habitat type, topography). Second, the sampling effort should be apportioned equally across the road effect zone, as the road effect of concern may vary significantly within this zone. The effect-size of the road—and consequently the effect-size of road mitigation measures—will be often at its maximum in close proximity to the road. However, situations occur where the opposite is true, e.g., due to an increase in suitable edge habitat at the roadside (Mumme et al. 2000) or due to home range pile-up adjacent to the road due to barrier effects (Riley et al. 2006). It is often necessary to do a best guess about where the road effect zone ends.

NSAIDs decrease the glomerular filtration rate when given to those with effective volume depletion, such as exercising endurance athletes [69]. Hew et al.[42] reported that up to 50-60% of the athletes are consuming NSAIDs. Thermal stress in these athletes was mild to moderate; a higher thermal stress might have altered fluid status to a larger extent. A further limitation was that we did not differ between athletes wearing compression socks and athletes without compression socks. A recent study showed that compression socks improved running performance

[70] and athletes may nowadays use more frequently compressions socks during races. The use of compression socks might have influenced

the post-race volume of the lower leg. Since oedemata develop over the course of multi-day events, it would be interesting PLX-4720 manufacturer to repeat this study for a standard Ironman triathlon conducted in hot weather. It would also be interesting to follow the time course of developing and receding oedemata in multi-stage ultra-marathons. A recent study showed that body mass decreased after each stage and reached pre-race value by the morning of the next day in a multi-stage mountain ultra-marathon [71]. Finally, it would be interesting to chart the time-course of oedemata ‘growing in’ as well as receding in future studies. Conclusions To summarize, the volume of the lower extremity decreased and this decrease was unrelated to fluid intake in the present male Ironman triathletes. We found no increase in the thickness of adipose subcutaneous tissue of the hands and feet. Roscovitine price 3-mercaptopyruvate sulfurtransferase Renal function was altered. Serum [Na+ was maintained and serum osmolality increased because body mass decreased. Considering the findings of Milledge et al.[2] and Williams et al.[1], the duration of an Ironman triathlon was presumably too short to find significant disturbances in body fluid homeostasis. Also the athletes in the race faced only a mild to moderate thermal stress. Future studies on longer triathlon distances such as a Triple Iron ultra-triathlon and

races under higher thermal stress may be more appropriate to find a disturbance in body fluid homeostasis leading to peripheral oedemata in triathletes. In these athletes, the prevalence of EAH is considerably higher compared to Ironman triathletes and therefore the risk for fluid overload might be higher [72]. For future studies, peripheral quantitative computed tomography (pqCT) might be used to estimate changes in muscle and fat in the lower leg [73]. Acknowledgements We thank Mary Miller for her help in translation. References 1. Williams ES, Ward MP, Milledge JS, Withey WR, Older MW, Forsling ML: Effect of the exercise of seven consecutive days hill-walking on fluid homeostasis. Clin Sci 1979, 56:305–331.PubMed 2.

The Netherlands is divided in 11 separate trauma regions, each region contains a level one trauma center [8]. In this ITF2357 clinical trial study prospective data from the Dutch National Trauma Database (DNTD) for the area Central Netherlands were used. The DNTD contains documentation on all trauma patients that are treated at the emergency department and subsequently admitted. Data in the DNTD were collected in a standardized manner and include detailed information on demographics, trauma event and mechanism, primary trauma survey, initial treatment and injuries. Injuries were diagnosed at primary survey, subsequent surgery or during admission. Thoracic

and pelvic x-ray imaging were performed for all trauma patients and when indicated supplemented with ultrasound and computed tomography (CT). The database accuracy is constantly evaluated by two database managers. All injuries were coded using Abbreviated Injury Scale (AIS) location codes allocated to one of the six body regions (head and neck, face, chest, abdomen, extremities and external) to calculate the Injury of Severity Score (ISS) [9]. Patients with a clavicle fracture were selected using AIS location codes. The ISS provides an overall score for patients with multiple injuries and is used to determine injury severity; 0 corresponds with no injury, the maximum score of 75

corresponds with injury leading to death [10]. Patients with an ISS ≥ 16, obtained from ≥2 AIS regions and physiological alterations due to the injuries are considered severely injured and were included in our analysis [11]. For these patients, age, gender, trauma mechanism, Raf activation injured side, additional injuries, department Thiamet G of admission (Intensive care Unit, Medium Care Unit, Operation Room) and discharge facility were collected from the DNTD. In all patients trauma mechanism was analysed and determined if it was a high energy trauma. The ATLS

definition for high energy trauma was used [5]. Furthermore death associated with the trauma was obtained from the electronic patient documentation (EPD). To evaluate the clavicle fractures we used the imaging studies performed. These radiological tests allowed for clear images of the fracture and of possible dislocation in anterior-posterior or cranial-caudal direction. Fractures were classified by the researchers (JL, SF and MH) using the Robinson classification. This classification divides the clavicle in a medial fifth (type 1), a diaphyseal part (type 2) and a lateral fifth (type 3). This is further divided by three other variables; intra-articular extent, degree of comminution, and degree of displacement [12]. Data analysis Mean numbers were noted with standard deviation (SD), median numbers were noted with interquartile range (IQR). Statistical analysis was performed using the χ 2 test for categorical variables and t-test and one-way-ANOVA for continuous variables.

Adv Mater Res 2010, 123:181–184.CrossRef 2. Korosec RC, Bukovec P: Sol–gel prepared NiO thin films for electrochromic applications. Acta Chim Slov 2006, 53:136–147. 3. Chan IM, Hong FC: Improved performance of the single-layer and double-layer organic light emitting diodes by nickel oxide coated indium tin oxide anode. Thin Solid Films 2004, 450:304–311.CrossRef 4. Hotovy I, Huran J, Siciliano P, Capone

S, Spiess L, Rehacek V: Enhancement of H 2 sensing properties of NiO-based thin films with a Pt surface modification. Sens Actuator B-Chem 2004, 103:300–311.CrossRef 5. Reguig BA, Khelil A, Cattin L, Morsli M, Bernède JC: Properties of NiO PF-02341066 order thin films deposited by intermittent spray pyrolysis process. Appl Surf Sci 2007, 253:4330–4334.CrossRef 6. Sato H, Minami T, Takata S, Yamada T: Transparent conducting p-type NiO thin films prepared by magnetron sputtering. Thin Solid Films 1993, 236:27–31.CrossRef 7. Hasan AJ, Mohammad-Mehdi BM, Mehrdad SS: Nickel–lithium oxide alloy transparent conducting films deposited by spray pyrolysis technique. J Alloy Comp 2011,

509:2770–2773.CrossRef 8. Joseph DP, Saravanan M, Muthuraaman B, Renugambal P, Sambasivam S, Raja SP, Maruthamuthu P, Venkateswaran C: Spray deposition and characterization of nanostructured Li doped NiO thin films for application in dye-sensitized solar cells. Nanotechnology EX 527 mouse 2008, 19:485707.CrossRef 9. Ohta H, Kamiya M, Kamiya T, Hirano M, Hosono H: UV-detector based on pn-heterojunction diode composed of transparent oxide semiconductors, p-NiO/n-ZnO. Thin Solid Films 2003, 445:317–321.CrossRef new 10. Mattheiss LF: Electronic structure of the 3D transition-metal monoxides. I. Energy-band results. Phys Rev 1972, B5:209. 11. Chen X, Zhao L, Niu Q: Electrical and optical properties of p-type Li, Cu-codoped NiO thin films. J Electro Mater 2012, 41:3382–3386.CrossRef 12. Jang WL, Lu YM, Hwang WS,

Chen WC: Electrical properties of Li-doped NiO films. J Eur Ceram Soc 2010, 30:503–508.CrossRef 13. Yu GH, Zhu FW, Chai CL: X-ray photoelectron spectroscopy study of magnetic films. Appl Phys A 2003, 76:45–47.CrossRef 14. Oswald S, Bruckner W: XPS depth profile analysis of non-stoichiometric NiO films. Surf Interface Anal 2004, 36:17–22.CrossRef 15. Tanaka S, Taniguchi M, Tanigawa H: XPS and UPS studies on electronic structure of Li 2 O. Nucl J Mater 2000, 283–287:1405–1408.CrossRef 16. Dedryvère R, Laruelle S, Grugeon S, Poizot P, Gonbeau D, Tarascon JM: Contribution of X-ray photoelectron spectroscopy to the study of the electrochemical reactivity of CoO toward lithium. Chem Mater 2004, 16:1056–1061.CrossRef 17. Wu QH, Thissen A, Jaegermann W: Photoelectron spectroscopic study of Li oxides on Li over-deposited V 2 O 5 thin film surfaces. Appl Surf Sci 2005, 250:57–62.CrossRef 18. Lu YM, Hwang WS, Yang JS: Effect of substrate temperature on the resistivity of non-stoichiometric sputtered NiO x films. Surf Coat Technol 2002, 155:231–235.